Cancer Spectrum and Gene-Specific Patterns in Lynch Syndrome: Insights From 47 Families in a Brazilian Institutional Cohort
- 1 May 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (5) , e2500708
Abstract
PURPOSE: To characterize tumor-site distribution, age at diagnosis, sex distribution, and tumor multiplicity in a Brazilian institutional Lynch syndrome (LS) cohort stratified by mismatch repair (MMR) gene and genetic testing status, and to assess the impact of including nontested (NT) relatives. METHODS: We conducted a retrospective, registry-based family cohort study of families ascertained in 2013-2019 with pathogenic or likely pathogenic variants in MLH1 , MSH2 , MSH6 , PMS2 , or EPCAM . For each proband, pedigree enumeration was limited to one cancer-enriched parental lineage. Adults (≥18 years) were included for tumor-site analyses. Relatives were classified as carriers (genotype-confirmed), noncarriers, or NT. Only primary malignant tumors were counted. Outcomes were any primary malignancy, multiplicity (≥2 primaries), age at first primary, and gene-specific tumor profiles summarized per person and per tumor. RESULTS: Forty-seven families comprised 729 relatives; 111 (15.2%) underwent testing, identifying 78 carriers. Cohort composition was 78 (10.7%) carriers, 33 (4.5%) noncarriers, and 618 (84.8%) NT. Carriers were more often affected (≥1 tumor: 64.1% v 37.9% NT v 18.2% noncarriers), younger at first cancer (mean 42.3 v 47.3 years in NT), and more likely to have multiple primaries. Colorectal cancer predominated across genes; endometrial tumors were more frequent in MLH1/MSH2 , and urothelial tumors clustered in MSH2 (descriptive). After false discovery rate control across LS-spectrum sites, site-wise multigene contrasts were not significant. CONCLUSION: Carriers showed earlier onset and higher multiplicity, with gene-linked patterns consistent with LS heterogeneity. Low testing uptake broadened observed spectra among NT relatives, supporting cascade testing and genotype-tailored surveillance.Keywords
This publication has 16 references indexed in Scilit:
- Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databaseeClinicalMedicine, 2023
- Clinicopathological and molecular characterization of Brazilian families at risk for Lynch syndromeCancer Genetics, 2021
- A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registriesEuropean Journal of Cancer, 2019
- From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin AmericaInternational Journal of Cancer, 2018
- Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch SyndromeCancer Medicine, 2018
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registryFamilial Cancer, 2010
- Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1Nature Genetics, 2008
- Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional RegistryFamilial Cancer, 2004
- New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆Gastroenterology, 1999